How many insider trades does FilingIQ track for CPIX?

FilingIQ tracks 4,066 Form 4 insider transactions for CPIX (CUMBERLAND PHARMACEUTICALS INC), covering filings from Mar 19, 2015 onwards. 12 of those were filed in the last 90 days.

Are CPIX insiders net buyers or net sellers?

Across the full Form 4 history for CPIX, 2,745 transactions (68%) were open-market purchases and 86 (2%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CPIX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CPIX in?

CUMBERLAND PHARMACEUTICALS INC (CPIX) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $58.27M.

CPIX insider trading

NasdaqGS Healthcare

CUMBERLAND PHARMACEUTICALS INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

4,066

Last 90 days

Buys / sells

68% / 2%

Market cap

$58.27M

About CUMBERLAND PHARMACEUTICALS INC

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, an injection for the prevention of nausea and vomiting for patients receiving chemotherapy treatment; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of the cardiomyopathy associate with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, and aspirin-exacerbated respiratory disease; and is in Phase II clinical trial for the treatment of systemic sclerosis and idiopathic pulmonary fibrosis. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Company website: www.cumberlandpharma.com

CPIX insider activity at a glance

FilingIQ has scored 4,066 insider transactions for CPIX since Mar 19, 2015. The most recent filing in our index is dated Mar 18, 2026.

Across the full history, 2,745 open-market purchases and 86 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CPIX insider trades is 43.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CPIX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for CPIX?: FilingIQ tracks 4,066 Form 4 insider transactions for CPIX (CUMBERLAND PHARMACEUTICALS INC), covering filings from Mar 19, 2015 onwards. 12 of those were filed in the last 90 days.
Are CPIX insiders net buyers or net sellers?: Across the full Form 4 history for CPIX, 2,745 transactions (68%) were open-market purchases and 86 (2%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CPIX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CPIX in?: CUMBERLAND PHARMACEUTICALS INC (CPIX) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $58.27M.

Methodology & sources

Every CPIX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.